Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Larson

Showing results (1231-1240 of 1,352) with videos related to

Pageof 136
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphomaF M Foss, A Raubitscheck, J L Mulshine, et al.
Investigative Ophthalmology & Visual Science|August 29, 2007
Analysis of ocular hypopigmentation in Rab38cht/cht miceBrian P Brooks, Denise M Larson, Chi-Chao Chan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network studySteven Attia, Anne M Traynor, Kyungmann Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancerDana E Rathkopf, Michael J Morris, Josef J Fox, et al.
Current Biology : CB|April 9, 2021
Rhesus macaques build new social connections after a natural disasterCamille Testard, Sam M Larson, Marina M Watowich, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2025
PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinomaCharlie White, Vetri Sudar Jayaprakasam, Megan Tenet, et al.
Prostate Cancer and Prostatic Diseases|November 11, 2018
Quantification of bone flare on <sup>18</sup>F-NaF PET/CT in metastatic castration-resistant prostate cancerAmy J Weisman, Stephanie A Harmon, Timothy G Perk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Medical and Pediatric Oncology|July 24, 2001
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of ageN K Cheung, B H Kushner, M LaQuaglia, et al.
ACS Applied Materials & Interfaces|January 24, 2020
Heterogenized Pyridine-Substituted Cobalt(II) Phthalocyanine Yields Reduction of CO<sub>2</sub> by Tuning the Electron Affinity of the Co CenterAlberto De Riccardis, Michelle Lee, Roman V Kazantsev, et al.
Pageof 136

Showing results (1231-1240 of 1,352) with videos related to

Sort By:
Pageof 136
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphomaF M Foss, A Raubitscheck, J L Mulshine, et al.
Investigative Ophthalmology & Visual Science|August 29, 2007
Analysis of ocular hypopigmentation in Rab38cht/cht miceBrian P Brooks, Denise M Larson, Chi-Chao Chan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network studySteven Attia, Anne M Traynor, Kyungmann Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancerDana E Rathkopf, Michael J Morris, Josef J Fox, et al.
Current Biology : CB|April 9, 2021
Rhesus macaques build new social connections after a natural disasterCamille Testard, Sam M Larson, Marina M Watowich, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2025
PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinomaCharlie White, Vetri Sudar Jayaprakasam, Megan Tenet, et al.
Prostate Cancer and Prostatic Diseases|November 11, 2018
Quantification of bone flare on <sup>18</sup>F-NaF PET/CT in metastatic castration-resistant prostate cancerAmy J Weisman, Stephanie A Harmon, Timothy G Perk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.
Medical and Pediatric Oncology|July 24, 2001
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of ageN K Cheung, B H Kushner, M LaQuaglia, et al.
ACS Applied Materials & Interfaces|January 24, 2020
Heterogenized Pyridine-Substituted Cobalt(II) Phthalocyanine Yields Reduction of CO<sub>2</sub> by Tuning the Electron Affinity of the Co CenterAlberto De Riccardis, Michelle Lee, Roman V Kazantsev, et al.
Pageof 136